#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	3450	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2447	311.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1573	1573	C	391	C,T	329,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	3450	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2447	311.4	0	HET	.	.	.	C207T,G,A	.	207	207	C	596	596	C	285	C,T,G,A	182,58,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	3450	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2447	311.4	0	HET	.	.	.	C451T,A,G	.	451	451	C	840	840	C	406	C,T,A,G	163,167,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6070	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3580	376.5	0	.	n	.	0	T695C	SNP	695	695	T	1168	1168	C	465	C,A,G	384,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6070	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3580	376.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2444	2444	C	381	C	319	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6070	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3580	376.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2518	2518	A	379	A	320	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6070	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3580	376.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3070	3070	C	379	C,A,T	321,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6070	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3580	376.5	0	HET	.	.	.	C1811T,G	.	1811	1811	C	2284	2284	C	368	C,T,G	158,162,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6070	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3580	376.5	0	HET	.	.	.	A1638G	.	1638	1638	A	2111	2111	A	330	A,G	232,60	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	262	folP	855	855	100.0	folP.l15.c4.ctg.1	1991	30.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1265	1267	AGC	43;43;45	A;G;C	37;37;35	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	568	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3929	32.9	1	SNP	p	S91F	1	.	.	271	273	TTC	879	881	TTC	47;47;47	T,G;T;C,G	38,1;40;37,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	568	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3929	32.9	1	SNP	p	D95G	1	.	.	283	285	GGC	891	893	GGC	49;49;49	G;G;C	41;41;39	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	568	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3929	32.9	1	SNP	p	G95N	0	.	.	283	285	GGC	891	893	GGC	49;49;49	G;G;C	41;41;39	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	204	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1771	26.6	1	SNP	p	G45D	0	.	.	133	135	GGC	721	723	GGC	50;50;50	G;G;C	39;39;38	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	136	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1519	20.0	0	.	n	.	0	A197.	DEL	197	197	A	859	859	A	56	A	43	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	496	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3404	32.8	1	SNP	p	D86N	0	.	.	256	258	GAC	875	877	GAC	30;30;33	G;A;C	24;24;29	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	496	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3404	32.8	1	SNP	p	R87I	0	.	.	259	261	CGT	878	880	CGT	33;33;33	C;G;T	29;27;28	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	496	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3404	32.8	1	SNP	p	S87R	1	.	.	259	261	CGT	878	880	CGT	33;33;33	C;G;T	29;27;28	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	496	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3404	32.8	1	SNP	p	R87W	0	.	.	259	261	CGT	878	880	CGT	33;33;33	C;G;T	29;27;28	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	496	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3404	32.8	1	SNP	p	S88P	0	.	.	262	264	TCC	881	883	TCC	33;34;34	T;C;C	26;29;31	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	382	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3109	28.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1728	1730	GGC	32;32;32	G;G;C	26;25;24	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	466	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2612	39.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1458	1460	GCC	40;40;40	G;C,G;C	36;36,1;36	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	466	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2612	39.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1461	1463	ATG	39;39;38	A;T;G	36;36;35	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	466	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2612	39.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1473	1475	ACC	42;42;42	A;C;C	37;38;38	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	466	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2612	39.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1473	1475	ACC	42;42;42	A;C;C	37;38;38	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	466	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2612	39.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1974	1976	ACC	42;42;42	A;C;C	35;35;38	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	466	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2612	39.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2028	2030	GCG	37;38;38	G;C;G	29;31;33	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	466	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2612	39.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2028	2030	GCG	37;38;38	G;C;G	29;31;33	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	466	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2612	39.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2151	2153	GGT	31;31;31	G;G,T,C;T,G	28;26,1,1;26,2	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	466	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2612	39.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2160	2162	AGC	29;28;28	A;G,C;C,G	22;21,1;21,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	466	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2612	39.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2178	2180	CCG	27;27;27	C;C;G	21;19;18	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1016	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3558	63.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1818	1820	CCG	60;60;60	C,G;C;G	46,1;48;41	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	296	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2217	31.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	782	782	C	28	C	21	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	42	porB1a	984	285	91.0	porB1a.l15.c4.ctg.1	1072	7.6	0	.	p	.	0	H217N	NONSYN	649	651	CAT	812	814	AAT	14;14;14	A;A;T,C	11;11;10,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	42	porB1a	984	285	91.0	porB1a.l15.c4.ctg.1	1072	7.6	0	.	p	.	0	D218N	NONSYN	652	654	GAT	815	817	AAT	14;14;14	A;A;T	11;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	42	porB1a	984	285	91.0	porB1a.l15.c4.ctg.1	1072	7.6	0	.	p	.	0	V226A	NONSYN	676	678	GTA	839	841	GCA	9;9;9	G;C;A	5;6;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	42	porB1a	984	285	91.0	porB1a.l15.c4.ctg.1	1072	7.6	0	.	p	.	0	.	MULTIPLE	700	702	ACT	862	864	GTA	8;8;8	G;T;A	6;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	42	porB1a	984	285	91.0	porB1a.l15.c4.ctg.1	1072	7.6	0	.	p	.	0	N237fs	FSHIFT	709	709	A	871	871	A	8	A	6	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	430	porB1b	1038	1038	99.9	porB1b.l6.c17.ctg.1	1987	48.3	0	.	p	.	0	R40Q	NONSYN	118	120	CGG	552	554	CAG	62;62;62	C;A;G	57;56;59	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	430	porB1b	1038	1038	99.9	porB1b.l6.c17.ctg.1	1987	48.3	1	SNP	p	G120K	1	.	.	358	360	AAG	792	794	AAG	58;58;59	A,G;A;G	47,1;50;47	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	430	porB1b	1038	1038	99.9	porB1b.l6.c17.ctg.1	1987	48.3	1	SNP	p	A121N	1	.	.	361	363	AAC	795	797	AAC	59;59;59	A;A,C;C	47;50,1;48	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	430	porB1b	1038	1038	99.9	porB1b.l6.c17.ctg.1	1987	48.3	1	SNP	p	N121D	0	.	.	361	363	AAC	795	797	AAC	59;59;59	A;A,C;C	47;50,1;48	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1618	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5411	68.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	218	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1643	32.7	1	SNP	p	V57M	1	.	.	169	171	ATG	937	939	ATG	77;76;76	A;T;G,T	69;70;69,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
